These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 16423508)

  • 1. Systemic immunomodulatory effects of Polypodium leucotomos as an adjuvant to PUVA therapy in generalized vitiligo: A pilot study.
    Reyes E; Jaén P; de las Heras E; Carrión F; Alvarez-Mon M; de Eusebio E; Alvare M; Cuevas J; González S; Villarrubia VG
    J Dermatol Sci; 2006 Mar; 41(3):213-6. PubMed ID: 16423508
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of vitiligo vulgaris with narrow-band UVB and oral Polypodium leucotomos extract: a randomized double-blind placebo-controlled study.
    Middelkamp-Hup MA; Bos JD; Rius-Diaz F; Gonzalez S; Westerhof W
    J Eur Acad Dermatol Venereol; 2007 Aug; 21(7):942-50. PubMed ID: 17659004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized double-blind trial of treatment of vitiligo: efficacy of psoralen-UV-A therapy vs Narrowband-UV-B therapy.
    Yones SS; Palmer RA; Garibaldinos TM; Hawk JL
    Arch Dermatol; 2007 May; 143(5):578-84. PubMed ID: 17519217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autologous cultured melanocytes in vitiligo treatment.
    Czajkowski R; Placek W; Drewa T; Kowaliszyn B; Sir J; Weiss W
    Dermatol Surg; 2007 Sep; 33(9):1027-36; discussion 1035-6. PubMed ID: 17760593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The efficacy of combined PUVA and low-dose azathioprine for early and enhanced repigmentation in vitiligo patients.
    Radmanesh M; Saedi K
    J Dermatolog Treat; 2006; 17(3):151-3. PubMed ID: 16854754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized, placebo-controlled, double-blind trial comparing narrowband UV-B Plus 0.1% tacrolimus ointment with narrowband UV-B plus placebo in the treatment of generalized vitiligo.
    Mehrabi D; Pandya AG
    Arch Dermatol; 2006 Jul; 142(7):927-9. PubMed ID: 16847214
    [No Abstract]   [Full Text] [Related]  

  • 7. Randomized, double-blind clinical trial to evaluate the efficacy of topical tacalcitol and sunlight exposure in the treatment of adult nonsegmental vitiligo.
    Rodríguez-Martín M; García Bustínduy M; Sáez Rodríguez M; Noda Cabrera A
    Br J Dermatol; 2009 Feb; 160(2):409-14. PubMed ID: 19016706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-dose prednisolone and psoralen ultraviolet A combination therapy in 36 patients with vitiligo.
    Lee Y; Seo YJ; Lee JH; Park JK
    Clin Exp Dermatol; 2007 Sep; 32(5):499-501. PubMed ID: 17608760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psoralen and ultraviolet A and narrow-band ultraviolet B in inducing stability in vitiligo, assessed by vitiligo disease activity score: an open prospective comparative study.
    Bhatnagar A; Kanwar AJ; Parsad D; De D
    J Eur Acad Dermatol Venereol; 2007 Nov; 21(10):1381-5. PubMed ID: 17958845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of systemic PUVA and NB-UVB in the treatment of vitiligo: an open prospective study.
    Bhatnagar A; Kanwar AJ; Parsad D; De D
    J Eur Acad Dermatol Venereol; 2007 May; 21(5):638-42. PubMed ID: 17447977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Long-term effects of PUVA therapy on Israeli patients with vitiligo].
    Vussuki E; Ziv M; Rosenman D; David M
    Harefuah; 2006 Jul; 145(7):483-5, 552, 551. PubMed ID: 16900734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of melanocytes transplantation methods for the treatment of vitiligo.
    Czajkowski R
    Dermatol Surg; 2004 Nov; 30(11):1400-5. PubMed ID: 15522021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can topical phenytoin augment the therapeutic efficacy of PUVA against vitiligo? A double-blind, randomized, bilateral-comparison, placebo-controlled study.
    Bahmani M; Fallahzadeh MK; Jowkar F; Khalesi M; Bahri-Najafi R; Namazi MR
    J Dermatolog Treat; 2011 Apr; 22(2):106-8. PubMed ID: 20443664
    [No Abstract]   [Full Text] [Related]  

  • 14. Combination of 308-nm xenon chloride excimer laser and topical calcipotriol in vitiligo.
    Goldinger SM; Dummer R; Schmid P; Burg G; Seifert B; Läuchli S
    J Eur Acad Dermatol Venereol; 2007 Apr; 21(4):504-8. PubMed ID: 17373978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polypodium leucotomos as an adjunct to the treatment of vitiligo.
    Searle T; Al-Niaimi F; Ali FR
    J Am Acad Dermatol; 2022 Feb; 86(2):e65. PubMed ID: 34390787
    [No Abstract]   [Full Text] [Related]  

  • 16. Vitiligo treatment with a combination of PUVA therapy and epidermal autografts.
    Skouge J; Morison WL
    Arch Dermatol; 1995 Nov; 131(11):1257-8. PubMed ID: 7503568
    [No Abstract]   [Full Text] [Related]  

  • 17. The efficacy of pimecrolimus 1% cream plus narrow-band ultraviolet B in the treatment of vitiligo: a double-blind, placebo-controlled clinical trial.
    Esfandiarpour I; Ekhlasi A; Farajzadeh S; Shamsadini S
    J Dermatolog Treat; 2009; 20(1):14-8. PubMed ID: 18608735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Vitiligo--loss of cutaneous pigmentation].
    Sitek JC
    Tidsskr Nor Laegeforen; 2006 Sep; 126(18):2370-2. PubMed ID: 16998548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Photoprotective activity of oral polypodium leucotomos extract in 25 patients with idiopathic photodermatoses.
    Caccialanza M; Percivalle S; Piccinno R; Brambilla R
    Photodermatol Photoimmunol Photomed; 2007 Feb; 23(1):46-7. PubMed ID: 17254039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polypodium leucotomos as an Adjunct Treatment of Pigmentary Disorders.
    Nestor M; Bucay V; Callender V; Cohen JL; Sadick N; Waldorf H
    J Clin Aesthet Dermatol; 2014 Mar; 7(3):13-7. PubMed ID: 24688621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.